4Fukujima MM Martinez TL,Pinto LE,et al.Fibrinogen as independent risk factor for ischemic stroke[].Arquivos de Neuropsiquiatria.1997
5Jin L,Jin H,Zhang G,et al.Changes in coagulation and tisssue plasminogen activator after the treatment of cerebral infarction with humbrokinase[].Clinical Hemorheology.2000
5Mauriello A, Sangiorgi G, Palmieri G, et al. Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks [ J ].Circulation, 2000, 101 (7): 744- 750.
6Cuomo O, Pignataro G, Gala R, et al. Antithrombin reduces ischemie volume, ameliorates neurologic deficits, and prolongs animal survival in both transient and perma- nent focal ischemia [ J]. Stroke, 2007, 38 (12) : 3272 - 3279.
9Tohgi H, Takahashi H, Chiba K, et al. Coagulation- fibrinolysis system in poststroke patients receiving antiplatelet medication [J]. Stroke, 1993, 24(6): 801-804.
10Yamazaki M, Uchiyama S, Maruyama S. Alterations of haemostatic markers in various subtypes and phases of stroke[J]. Blood Coagul Fibrinolysis, 1993, 4 (5) : 707-712.
